Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
P/E ratio for Outset Medical, Inc. (OM)
P/E ratio as of 2023: -1.55
According to Outset Medical, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.55. At the end of 2022 the company had a P/E ratio of -7.63.
P/E ratio history for Outset Medical, Inc. from 2018 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -1.55 |
| 2022 | -7.63 |
| 2021 | -15.93 |
| 2020 | -20.12 |
| 2019 | -37.61 |
| 2018 | -36.67 |